epl oil acquired energy xxi 23 bln
new york march 12 reuters us stocks little changed wednesday equities recouped much earlier declines amid signs progress diplomatic attempts ease tensions surrounding ukraine
us secretary state john kerry meet russian counterpart sergei lavrov london friday ahead referendum sunday whether ukraines crimean peninsula join russia go independent
people kind reassessing looking headline thinking maybe going turn disaster russia ukraine said ken director nyse floor division securities new york
good talking good kerry going weekend something friday allay fear weekend positive
stocks fallen earlier session concerns weakening economy china london copper seen proxy chinas economic health rebounded hitting lowest level since july 2010
geopolitical developments moved forefront week dearth fresh corporate results economic data offered catalysts push benchmark sp index recent record close friday
weve climbed far continue climb definitely going seesaw move said rick meckler president libertyview capital management jersey city new jersey
ukraines government appealed western help tuesday stop moscow annexing crimea black sea peninsula overrun russian troops seemed fixed course could formalize rule moscow within days
eu member states agreed wording sanctions russia including travel restrictions asset freezes responsible violating sovereignty ukraine according draft document seen reuters
dow jones industrial average fell points 009 percent sp 500 lost 216 points 012 percent nasdaq composite added points 015 percent
epl oil gas inc jumped 294 percent company agreed acquired larger rival energy xxi ltd 23 billion including debt energy xxi shares lost 63 percent 2190
express inc dropped 113 percent apparel retailer reported fourthquarter earnings forecast profit current quarter fell far short analyst expectations
oxigene inc surged 1037 percent 493 company said experimental drug zybrestat combined roches cancer drug avastin significantly slowed progression recurrent ovarian cancer better avastin alone midstage clinical trial
geron corp plunged 632 percent 182 company said us food drug administration ordered halt trials cancer drug imetelstat concerns potential liver damage editing bernadette baum nick
